Literature DB >> 15509025

Pharmacokinetics and bioavailability of florfenicol following intravenous, intramuscular and oral administrations in rabbits.

A M Abd El-Aty1, A Goudah, K Abo El-Sooud, H Y El-Zorba, M Shimoda, H H Zhou.   

Abstract

This study examined the disposition kinetics and bioavailability of florfenicol after intravenous (i.v.), intramuscular (i.m.) and oral administration to rabbits at a dose of 30 mg/kg BW. Serial blood samples were collected through an indwelling catheter intermittently for 24 h for various routes. Plasma antibacterial concentrations were determined using a microbiological assay method with Bacillus subtilis ATCC 6633 as a reference organism. Plasma concentration-time data generated in the present study were analysed by non-compartmental methods based on statistical moment theory. Following i.v. administration, the overall elimination half-life (t1/2beta) was 1.54 h, mean residence time (MRT) was 1.69 h, mean volume of distribution at steady-state (Vdss) was 0.57 L/kg, and total body clearance (Cltot) was 0.34 L/kg/h. After i.m. and oral dosing, the terminal part of the curve should correspond to the absorption phase, instead of to the elimination phase, with terminal half-lives of 3.01 and 2.57 h, respectively. The mean absorption time (MAT) was 2.65 h for i.m. and 2.01 h for oral administration. Elimination rate constants differed with i.v., i.m. and oral administrations, suggesting a flip-flop situation. The observed mean peak plasma concentrations (Cmax obs) were 21.65 and 15.14 microg/ml achieved at a post-injection time (Tmax obs) of 0.5 h following i.m. and oral dosing, respectively. The absolute systemic availabilities were 88.25% and 50.79%, respectively, and the extent of plasma protein binding percent was 11.65%.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15509025     DOI: 10.1023/b:verc.0000040241.06642.49

Source DB:  PubMed          Journal:  Vet Res Commun        ISSN: 0165-7380            Impact factor:   2.459


  14 in total

Review 1.  The pharmacokinetic-pharmacodynamic approach to a rational dosage regimen for antibiotics.

Authors:  P L Toutain; J R E del Castillo; A Bousquet-Mélou
Journal:  Res Vet Sci       Date:  2002-10       Impact factor: 2.534

2.  Tissue concentrations and pharmacokinetics of florfenicol in broiler chickens.

Authors:  N A Afifi; K A Abo el-Sooud
Journal:  Br Poult Sci       Date:  1997-09       Impact factor: 2.095

3.  Pharmacokinetic properties of florfenicol in Egyptian goats.

Authors:  M Atef; A Y el-Gendi; M M Aziza; A M Abd El-Aty
Journal:  Dtsch Tierarztl Wochenschr       Date:  2000-04

4.  Pharmacodisposition of thiamphenicol in rabbits.

Authors:  A M Abd El-Aty; K Abo El Sooud; A M Goudah
Journal:  Dtsch Tierarztl Wochenschr       Date:  2001-09

5.  Reproductive assessment by continuous breeding: evolving study design and summaries of ninety studies.

Authors:  R E Chapin; R A Sloane
Journal:  Environ Health Perspect       Date:  1997-02       Impact factor: 9.031

6.  In vitro antibacterial activity of fluorinated analogs of chloramphenicol and thiamphenicol.

Authors:  V P Syriopoulou; A L Harding; D A Goldmann; A L Smith
Journal:  Antimicrob Agents Chemother       Date:  1981-02       Impact factor: 5.191

7.  Pharmacokinetics of florfenicol following intravenous and intramuscular doses to cattle.

Authors:  R D Lobell; K J Varma; J C Johnson; R A Sams; D F Gerken; S M Ashcraft
Journal:  J Vet Pharmacol Ther       Date:  1994-08       Impact factor: 1.786

8.  In vitro activity of chloramphenicol and thiamphenicol analogs.

Authors:  H C Neu; K P Fu
Journal:  Antimicrob Agents Chemother       Date:  1980-08       Impact factor: 5.191

9.  Pharmacokinetics of florfenicol in normal and Pasteurella-infected Muscovy ducks.

Authors:  H A el-Banna
Journal:  Br Poult Sci       Date:  1998-09       Impact factor: 2.095

10.  Pharmacokinetics of florfenicol in healthy pigs and in pigs experimentally infected with Actinobacillus pleuropneumoniae.

Authors:  Jianzhong Liu; Ki-Fai Fung; Zhangliu Chen; Zhenling Zeng; Jie Zhang
Journal:  Antimicrob Agents Chemother       Date:  2003-02       Impact factor: 5.191

View more
  5 in total

Review 1.  Flip-flop pharmacokinetics--delivering a reversal of disposition: challenges and opportunities during drug development.

Authors:  Jaime A Yáñez; Connie M Remsberg; Casey L Sayre; M Laird Forrest; Neal M Davies
Journal:  Ther Deliv       Date:  2011-05

2.  Few Drugs Display Flip-Flop Pharmacokinetics and These Are Primarily Associated with Classes 3 and 4 of the BDDCS.

Authors:  Kimberly L Garrison; Selma Sahin; Leslie Z Benet
Journal:  J Pharm Sci       Date:  2015-05-25       Impact factor: 3.534

3.  Influence of three coccidiostats on the pharmacokinetics of florfenicol in rabbits.

Authors:  Chun Liu; Sheng-Jie Wang; Qian Zhang; Yi-Xiang Shao
Journal:  Exp Anim       Date:  2014-10-16

4.  Effects of anemoside B4 on pharmacokinetics of florfenicol and mRNA expression of CXR, MDR1, CYP3A37 and UGT1E in broilers.

Authors:  Sicong Li; Xuting Li; Rui Yang; Bin Wang; Jinliang Li; Liang Cao; Songyang Xiao; Wei Huang
Journal:  J Vet Med Sci       Date:  2019-10-14       Impact factor: 1.267

5.  Comparative muscle irritation and pharmacokinetics of florfenicol-hydroxypropyl-β-cyclodextrin inclusion complex freeze-dried powder injection and florfenicol commercial injection in beagle dogs.

Authors:  Guoqing Fan; Li Zhang; Yun Shen; Gang Shu; Zhixiang Yuan; Juchun Lin; Wei Zhang; Guangneng Peng; Zhijun Zhong; Lizi Yin; Hualin Fu
Journal:  Sci Rep       Date:  2019-11-13       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.